DO NOT USE FOR CLINICAL PRACTICE
Please use current guidelines available on the UHNM intranet for patient treatment
Please use current guidelines available on the UHNM intranet for patient treatment
RECOGNITION AND ASSESSMENT
- Contrast Associated Acute Kidney Injury (CA-AKI) is approximately 12% of all cases of hospital-acquired renal failure; defined when one of the following criteria is met:
- serum creatinine rises >26 µmol/L within 48 hr
- serum creatinine rises 1.5 fold from baseline value, which is known or presumed to have occurred within 1 week
- urine output is <0.5 mL/kg/hr for >6 consecutive hr
- If a baseline serum creatinine within 1 week is not available, use the lowest creatinine value recorded within 3 months of episode of AKI
- Creatinine typically peaks 3–5 days after contrast administration
- returns to baseline within 2 weeks
- Only one in 200 patients requires renal replacement therapy
- AKI alert will be generated on all inpatients who have U&E and measure in line with the NHS England safety alert (June 2014)
IMMEDIATE TREATMENT
- No specific treatment
- Management is supportive. See Acute Kidney Injury: management guideline